Chief Accounting Officer
Pediatrix Medical Group, Inc. (MD)Equibles does not estimate personal net worth.
Get an email with a short summary when Pediatrix Medical Group, Inc. publishes a filing, an earnings call transcript or a press release.
Get MD alertsC. Marc Richards is recorded as Chief Accounting Officer at Pediatrix Medical Group, Inc. (MD) since November 16, 2021. Pediatrix Medical Group, Inc. reported in an 8-K filed August 6, 2024 that C. Marc Richards was terminated as Executive Vice President, Chief Financial Officer and Treasurer, effective October 1, 2024. The proxy statement of Pediatrix Medical Group, Inc. reports total compensation of $2,780,409 for C. Marc Richards in fiscal 2024, including a base salary of $375,000. Disclosed compensation is on record for 5 fiscal years. C. Marc Richards has spoken on 16 earnings calls across 1 company, most recently for Pediatrix Medical Group, Inc. on August 6, 2024. Pediatrix Medical Group, Inc. is classified in the Medical Care Facilities industry within the Healthcare sector. Other leadership on record at Pediatrix Medical Group, Inc. includes James D. Swift, M.D. (CEO, COO and Board Member), Mark S. Ordan (CEO and Chairman), Guy P. Sansone (Chairman and Board Member) and 7 others.
“Mr. Richards' transition from his role as Executive Vice President, CFO and Treasurer is a termination without "Cause" pursuant to that certain Amended and Restated Employment Agreement, dated April 26, 2023, by and between Mr. Richards and a wholly-owned subsidiary of the Company, and Mr. Richards will receive the benefits thereunder following the execution of a general release of claims in favor of the Company.”
“I'll provide some additional details in a few areas. Within our P&L, our G&A expense declined year-over-year despite the additional staffing we have put in place as part of our hybrid revenue cycle management structure.”
“I'll provide some additional details in a few areas. I'll start with cash flow. As a reminder, we are a user of cash in the first quarter of each year as we pay out incentive compensation and other benefits.”
“I'll provide some details for the quarter. Our same-unit volumes were mixed in the quarter, with hospital-based volumes declining somewhat offset by strong office-based volumes, specifically maternal fetal medicine.”
“I will provide some additional details for the quarter. Our adjusted EBITDA for the quarter was roughly $15 million below our internal forecast, primarily driven by practice-level operating expenses and also impacted by soft patient volumes.”
“I'll provide some additional details for the quarter. First, as Jim mentioned, we continued to decrease both our gross and net accounts receivable in the second quarter.”
2021-11-16–present
2020-10-01–present
Start not stated–2024-10-01
Medical Care Facilities · Healthcare
Chief Accounting Officer
2020-10-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Pediatrix Medical Group, Inc. (MD) | Former Executive Vice President, Chief Financial Officer | $375,000 | $2,780,409 |
| 2023 | Pediatrix Medical Group, Inc. (MD) | Former Executive Vice President, Chief Financial Officer | $500,000 | $1,783,676 |
| 2022 | Pediatrix Medical Group, Inc. (MD) | Former Executive Vice President, Chief Financial Officer | $500,000 | $1,909,595 |
| 2021 | Pediatrix Medical Group, Inc. (MD) | Executive Vice President and Chief Financial Officer | $500,000 | $2,688,952 |
| 2020 | Pediatrix Medical Group, Inc. (MD) | Executive Vice President and Chief Financial Officer | $157,197 | $1,967,008 |
